siti nur hidayah jamil, amatul hamizah ali, shevin rizal feroz, su datt lam, hani kartini agustar, mohd ridzuan mohd abd razak, jalifah latip.  (2023).  curcumin and its derivatives as potential antimalarial and anti inflammatory agents a review on structure activity relationship and mechanism of action.  - pharmaceuticals.  1-25. 

jufrizal syahri, rahmiwati hilma, amatul hamizah ali, norzila ismail, ng yee ling, nurlaili, beta achromi nurohmah, hani kartini agustar, lau yee ling, jalifah latip.  (2023).  chalcone mannich base derivatives: synthesis, antimalarial activities against plasmodium knowlesi, and molecular docking analysis.  - rsc advances.  36035-36047. 

janeeca sam,nadia aqilla shamsusah,amatul hamizah ali,rozita hod ,mohd rohaizat hassan,hani kartini agustar.  (2022).  prevalence of simian malaria among macaques in malaysia 2000 2021 a systematic review.  - plos neglected tropical diseases.  1-17. 

hooi-yuen khoo, hai-yen lee, chee-sieng khor, kim-kee tan, mohd rohaizat hassan, chin mun wong, hani kartini agustar, nadia aqilla s, syed sharizman sar, mohd saffree jeffree, nur athirah yusof, noor ain haron, zarina binti amin, rozita hod, sazaly ab.  (2022).  seroprevalence of zika virus among forest fringe communities in peninsular malaysia and sabah: general population-based study.  - american society of tropical medicine and hygiene.  560-568. 

amatul hamizah ali, suhaini sudi, ng shi jing, wan rozianoor mohd hassan, rusliza basir, hani kartini agustar, noor embi, hasidah mohd sidek, jalifah latip.  (2021).  dual antimalarial and gsk3beta mediated cytokine modulating activities of quercetin are requisite of its potential as a plant derived therapeutic in malaria.  - pharmaceuticals.  1-15. 

mohd asyraf shamsuddi, amatul hamizah ali, nur hanis zakaria, mohd fazli mohammat, ahmad sazali hamzah, zurina shaameri, kok wai lam, wun fui mark-lee, hani kartini agustar, mohd ridzuan mohd abd razak, jalifah latip & nurul izzaty hassan.  (2021).  synthesis, molecular docking, and antimalarial activity of hybrid 4-aminoquinoline-pyrano[2,3-c]pyrazole derivatives.  - pharmaceuticals.  1-17.